Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Serum Institute of India
Pharma
AstraZeneca, Hengrui, Takeda—Fierce Pharma Asia
AZ's CEO is eying innovation from China as the company plots a $1.5 billion ADC plant in Singapore. The FDA rejected a combo from Hengrui and Elevar.
Angus Liu
May 24, 2024 8:31am
SII ships first doses of Oxford, Novavax-partnered malaria shot
May 20, 2024 4:19pm
Takeda, Lilly-Innovent, BIO-China—Fierce Pharma Asia
May 10, 2024 9:30am
Merck's BCG monopoly could end
May 3, 2024 10:50am
Daiichi Sankyo, Glenmark, Serum-Biocon—Fierce Pharma Asia
Apr 28, 2023 8:35am
Serum Institute doubles its stake in Biocon Biologics to $300M
Apr 25, 2023 9:45am
